General Program Overview
• Rapidly evolving treatment landscape in prostate cancer
• Overview of treatment options for prostate cancer
• PARP inhibitors are novel therapies to treat prostate cancer with DNA damage response
(DDR) mutations
PARP, poly(ADP-ribose) polymerase